(firstQuint)A 12-month, Randomized, Efficacy and Safety Study of 0.

5 mg Ranibizumab vs Laser in Chinese DME Patients.

 Study to provide efficacy and safety data on 0.

5 mg ranibizumab intravitreal injections compared to laser photocaagulation in Chinese patients with visual impairment due to DME.

 Treatment is driven by achieving vision stabilization.

 A 12-month, Randomized, Efficacy and Safety Study of 0.

5 mg Ranibizumab vs Laser in Chinese DME Patients@highlight

Study of efficacy and safety of 0.

5 mg ranibizumab in Chinese patients with diabetic macular edema (DME)